Topic
PNB Vesper
COVID-19
24 Jun 2021
PNB Vesper to conduct Phase III clinical trials on covid drug, gets DCGI nod
PNB 001/ GPP-BALACOVIN is proving to be a breakthrough in COVID-19 treatment Kerala-based PNB Vesper has received DCGI permission to…
COVID-19
1 Apr 2021
PNB Vesper completes COVID-19 Phase 2 Clinical Trial
Submits report to DCGI and Government of India for Emergency Use Authorisation Kerala-based life sciences company PNB Vesper announced that…